News Archives - QualityStocks

FridayJun 26, 2026 12:00 pm

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

For decades, cardiovascular risk assessment has centered on a checklist of factors never designed to capture the full biological picture of how heart disease develops. What makes CHD numbers particularly troubling is that so much of this is preventable. Cardio Diagnostics has developed clinical tests rooted in epigenetics and genetics fields that examine how genes are expressed and regulated at the molecular level. Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings…

FridayJun 26, 2026 11:15 am

From Ownership to Utility: How Digital Assets Are Becoming Productive Capital

APUS is aligning its treasury strategy with the shift from Bitcoin ownership to Bitcoin productivity via yield and digital credit markets MindWave is focused on institutional-grade custody, treasury optimization and compliant digital asset infrastructure The updates highlight MindWave’s broader mission: to enable institutions to transform Bitcoin from a passive reserve asset into productive, yield-generating capital The digital asset industry is entering a new phase of development. While early blockchain adoption was largely driven by speculation and asset appreciation, today's market is increasingly focused on building sustainable financial infrastructure capable of supporting long-term institutional participation. Companies that can facilitate this transition…

FridayJun 26, 2026 10:30 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Before any new drug or diagnostic technology can be used widely, it must pass through a series of structured studies designed to answer specific questions. The milestone highlighted in Quantum BioPharma’s announcement is that patient enrollment in a key pilot study has reached its halfway mark. Preliminary analyses show a robust signal in acute MS lesions, along with potential sensitivity to gray matter lesions. Clinical studies are among the most demanding and consequential undertakings in medicine. They require years of planning, careful patient selection,…

FridayJun 26, 2026 9:45 am

Safe Pro Group Inc. (NASDAQ: SPAI) Delivers Against U.S. Army Order for Its Threat Analysis Kit

Safe Pro Group Inc. (NASDAQ: SPAI) has announced that it has delivered against a recent $742,000 U.S. Army order for the company’s Threat Analysis Kits. The delivered kits include Safe Pro’s edge compute AI powered Navigation Observation & Detection Engine (“NODE”), Black Widow drones from Red Cat Holdings, annual AI model and algorithm software upgrades and operational field analysis support. Safe Pro was awarded the subcontract and order from a Defense Prime Contractor on behalf of the Army which is seeking field-ready battlefield intelligence capability powered by advanced AI technology. Safe Pro Group (NASDAQ: SPAI), a mission-driven tech company that…

FridayJun 26, 2026 9:00 am

Fed Stress Test Shows Largest U.S. Banks Could Weather a Severe Recession

CNW CurrenSees Exploring the policies, markets and global events influencing currencies and the movement of money worldwide The Federal Reserve's annual stress test found all 32 large U.S. banks remained above minimum capital requirements under a severe recession scenario. Banks were projected to absorb more than $708 billion in loan losses while continuing to lend to households and businesses. The hypothetical scenario included a 39% decline in commercial real estate prices, a 30% drop in home prices and unemployment rising to 10%. June 26, 2026 – via CurrencyNewsWire -- According to the Federal Reserve's annual bank stress test, the nation's…

FridayJun 26, 2026 9:00 am

Wrap Technologies Inc. (NASDAQ: WRAP) Is ‘One to Watch’

The 10 cities with the largest police departments in the United States have paid out $1.02 billion for settlements and court judgements in police misconduct cases, with most centered around the improper use of force Wrap Technologies is well-positioned to establish a commanding position in supplying non-lethal tools to law enforcement departments globally Over 140 police departments across the United States received BolaWrap products in 2019, along with police departments in 19 other countries The company has received over 1,700 requests for demos, training and quotes from U.S. police departments, as well as over 600 requests from international markets Wrap…

ThursdayJun 25, 2026 11:15 am

QualityStocksNewsBreaks –Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Working with ExploreTech to Conduct Data Review and Drill Optimization at the Schryburt Lake REE-Niobium Project

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. ExploreTech is an exploration technology company that originated at Stanford University, developing an approach to exploration planning that’s more efficient than traditional methods. ExploreTech’s probabilistic modeling and drill planning solution pinpoints targets below cover, achieving the same or better drilling results with fewer boreholes. Recently, Canamera Energy Metals has engaged ExploreTech to deploy this technology at the Schryburt Lake REE-Niobium Project in Ontario, Canada. As the world becomes more reliant on technology and makes the shift to clean-energy, the critical metals they rely…

ThursdayJun 25, 2026 10:30 am

QualityStocksNewsBreaks –From Pilot to Scale: Manufacturing Partnerships and Commercialization in Service Robotics

TechForce Robotics has partnered with NUWA Robotics and Foxconn to support the transition from pilot deployments to scalable commercial production and enterprise rollout The company combines AI-driven robotics, enterprise automation infrastructure, and Robotics-as-a-Service capabilities to address growing demand for fleet-scale automation solutions Recent expansion into pharmaceutical automation broadens TechForce's addressable market while reinforcing its strategy of building a scalable robotics commercialization ecosystem TechForce Robotics, Inc. ("TechForce"), a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), is extending the boundaries of service robotics commercialization, moving its AI-powered automation platforms from pilot deployments into industrial-scale, revenue-generating fleet systems. Reputed for developing autonomous service…

ThursdayJun 25, 2026 9:45 am

Earth Science Tech Inc. (ETST) Presents Fiscal Year-End Financial Results for March 31, 2026, Operating a Diversified Holding Company Model

Earth Science Tech Inc. (OTC: ETST) recently reported year-end financial results for the fiscal year ending March 31, 2026 Earth Science Tech acquires, manages, and operates companies in pharmaceuticals, real estate, telemedicine, healthcare services, and other industries. Results include increases in revenue, gross profit, net income, and total assets. Earth Science Tech (OTC: ETST), a strategic holding company that acquires and manages a diverse portfolio of businesses, recently announced the financial results for the full fiscal year that ended on March 31, 2026 (https://ibn.fm/xRoIz). The reported results include: An 8% revenue increase compared to the year ended March 31, 2025,…

WednesdayJun 24, 2026 11:15 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology, demonstrating selective activity against cancer cells while sparing healthy cells in early testing. The company is presenting its BiTAC-ADC and BiTAC-TCE platforms for potential strategic collaborations at the BIO International Convention 2026. VERAXA’s proprietary BiTAC approach is designed to improve the precision of antibody-based cancer therapies by activating therapeutic effects only in targeted tumor cells. The company maintains a diversified oncology pipeline of antibody-based formats including antibody-drug conjugates (“ADCs”), T-cell engagers (“TCEs”), and other antibody-based formats. VERAXA recently began trading on the NASDAQ Capital Market under the…

Site Search

Company Search

Category: News